Taro Lamotrigine Tablets 100mg Recall: Cross Contamination with Enalapril Maleate
Taro Pharmaceuticals recalls 100-count Lamotrigine 100mg tablets contaminated with enalapril maleate. Affected products were manufactured in Israel with specific lot number and expiration date. Consumers should contact Taro for guidance.
Lower-risk recall
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Contact the company
What happened, in plain English
Taro Pharmaceuticals is recalling 100-count Lamotrigine 100mg tablets that were contaminated with enalapril maleate. This cross-contamination poses a risk of unintended medication interactions for people taking these drugs. Read more at govinfonow.com/recall/37500-taro-lamotrigine-tablets-100mg-recall-cross-contamination-with-enalapril-maleate.
Source Summary by GovInfoNow · govinfonow.com/recall/37500-taro-lamotrigine-tablets-100mg-recall-cross-contamination-with-enalapril-maleate · Updated October 5, 2026 · FDA enforcement record: FDA #D-0833-2020
Cite this page
“Taro Lamotrigine Tablets 100mg Recall: Cross Contamination with Enalapril Maleate.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37500-taro-lamotrigine-tablets-100mg-recall-cross-contamination-with-enalapril-maleate. Based on FDA recall #D-0833-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0833-2020%22&limit=1).
Why it’s dangerous
The tablets were contaminated with enalapril maleate, a medication that can interact with Lamotrigine. This cross-contamination could cause unintended medication interactions if taken together.
Who’s affected
People prescribed Lamotrigine 100mg tablets by a doctor who received this specific product batch. Those with other medications containing enalapril may be at higher risk.
How to tell if you have this one
Check for the 100-count bottle labeled 'Lamotrigine Tablets, USP, 100 mg, Rx Only' with lot number 331771 and expiration date June 2021. Products were distributed by Taro Pharmaceuticals U.S.A., Inc. in the United States.
- Brand
Taro Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 331771 and expiration date June 2021 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the U.S. and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0833-2020 (December 20, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0833-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.